#Investing in #Functional
and #Psychedelic #Mushrooms- #Stocks to watch- (OTC: $LRSV) (OTC: $MMEDF)
(OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco @NewWaveHolding @PSYBioLife @redlightholland
Point
Roberts WA, Delta, BC – April 19, 2021 - Investorideas.com, a leading
investor news resource covering functional mushrooms and plant-based food
alternatives releases a special report on the growing dominance of both
functional and psychedelic mushrooms in the current health and wellness sector,
featuring Link Reservations Inc. (OTC:
LRSV). Current medicinal trends and new research
point to the phenomenal promise of fungi for the future of food, medicine and
technology.
Read this news,
featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/04191LRSV-Psychedelic-Mushrooms.asp
Looking
at just one single mushroom, Reishi, is used in many modern health and wellness
products, according to Allied
Market Research,
“The global reishi mushroom market was valued at $3,096.9 million in 2019, and
is projected to reach $5,059.4 million by 2027, registering a CAGR of 8.1% from
2021 to 2027. In 2019, the powder reishi mushroom segment accounted for the
highest share in the reishi mushroom market size.”
Link Reservations
Inc.
(OTC:
LRSV),
a provider of wellness and cannabidiol (CBD) products for both humans and pets
just recently announced the launch and
availability to purchase DailyLife CBD
Immune, its immune boosting functional mushroom product. Featuring a combination
of CBD and a spectrum of functional mushrooms (including Lion’s Mane), the
tincture will be available for sale on the DailyLife CBD website.
“It
is my pleasure to announce that we have now launched our first functional
mushroom product. We have been researching the power of medicinal mushrooms for
some time and it is great to be able to bring to market a product that combines
the power of mushrooms with the anti-inflammatory benefits of CBD. The overall
goal is to offer natural products that can strongly benefit our health and,
with regards to DailyLife CBD Immune, to boost and maintain a healthy immune
system,” commented Rene Lauritsen, CEO at Link Reservations Inc. “Health and
wellbeing have been absolutely front of mind for everyone in the past 12
months, so creating a product that can naturally benefit people is a great
achievement,” he added.
DailyLife CBD Immune features an organic blend of 13
different medicinal mushrooms, including Lions Mane, Turkey Tail, Chaga, Red
Reishi, Cordyceps amongst others. By focusing on a variety of mushrooms, the
product is able to encompass multiple immune boosting traits and benefits. In
addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and
100mg of vitamin C which will add to the immune boosting benefits.
“We
are excited with the first launch of the functional mushroom range and we look
forward to see the reception while we work on the other projects in the
pipeline. We look forward to sharing more developments as they arise through
press releases,” ended Lauritsen.
Link
Reservations
isn’t alone in pivoting off CBD wellness products into the functional mushroom
category as NEW WAVE HOLDINGS CORP. (CSE:
SPOR)
(OTC:
TRMNF),
an investment issuer that provides capital and support services recently
announced
the launch of its first mushroom products in a new functional mushroom
collection, which will live under the Way of Will brand.
Way of Will, a natural wellness brand under
New Wave and known for its aromatherapy-based products, revealed earlier this
year that it will be introducing a new line of functional mushroom products in
the upcoming months. Further to the announcement, the company is releasing the
Functional Mushroom Powder and the Functional Mushroom Capsules from the
collection to the U.S. market. Paving the way to a larger collection of
specialty mushroom products, the mushroom powder and capsules will be the first
step in Way of Will's journey into the psychedelics space.
The product launch, featuring a house-blend
of five functional mushrooms and fungi available in both capsule and powder
format, aim to naturally boost immunity. They are loaded with vitamins,
nutrients, and antioxidants that support a healthy immune system. The capsules
are designed with ease of consumption and convenience in mind, while the powder
allows for versatile use by mixing and incorporating it into foods and
beverages.
"Mushrooms are gaining popularity
rapidly right now, but they're not a new phenomenon in food and medicine. They
have been used in certain regions of the world for centuries for a plethora of
health and wellness purposes," said Willie Tsang, founder and CEO of Way
of Will.
Goldman Small Cap Research, a stock market
research firm specializing in the small cap and microcap sectors, recently
announced that it has published a new research report on Link Reservations,
Inc. (OTC PINK:LRSV).. This report carries a
price target of 10
.
Looking
at the psychedelic mushroom space, which has been mostly dominated by news on
psilocybin, we are now just beginning to see growing interest in compounds
other than psilocin in psychoactive mushroom strains. PsyBio Therapeutics Corp. (TSXV:
PSYB),
a biotechnology company developing novel formulations of psychoactive
medications produced by genetically modified bacteria for the treatment of
mental health and other disorders and a leader in the field of psychedelic
research and drug development, has
initiated process development of its proprietary biosynthetic
formulation of norbaeocystin in collaboration with the Advanced Biofuels and
Bioproducts Process Development Unit, a scale-up facility managed by Lawrence
Berkeley National Laboratory, a US Department of Energy national laboratory.
Norbaeocystin is an analogue of psilocybin and is not a controlled substance.
The Company has commenced Phase I of this process, including analytical
chemistry technical transfer to establish detection methods for fermentation
products and key feedstocks and metabolites.
As both functional and psychoactive
mushrooms continue to grow in popularity, much as we have seen in the cannabis
industry, infrastructure and supply chains are the next hurdle the mushroom
industry must look to address. Red Light
Holland Corp. (CSE:
TRIP) (OTC:
TRUFF), an
Ontario-based corporation engaged in the production, growth and sale of a
premium brand of magic truffles to the legal, recreational market within the
Netherlands, recently
announced that
its wholly-owned subsidiary, RLH Netherlands B.V., has completed the acquisition
of SR Wholesale B.V., one of the
Netherlands' premiere distributors for quality psychedelic truffles. In 2020,
SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in
gross profit, with approximately $400,0001 of cash and working capital
currently on hand. SR Wholesale also distributes popular CBD products, cannabis
seeds, smart shop items, and headshop products, among others. SR Wholesale has
established a distribution network of over 400 companies that sell their
products across Europe, including working with sub-distributors which provide
products to over 1,000 shops in countries like the Netherlands, Germany, Spain,
Czech, Greece, UK, France, and Portugal.
Founded in 2017, SR Wholesale has grown to
become one of the most recognized and trusted distribution companies in the
Netherlands. In connection with the Acquisition, Red Light Holland announced
that Mr. Shai Ramsahai, Founder of SR Wholesale, has joined the Red Light
Holland team on closing as Vice-President to oversee the integration of SR
Wholesale into the Red Light Holland ecosystem, and grow the distribution
business for Red Light Holland globally. The acquisition will create immediate
synergies and enhance Red Light Holland's growth and expansion strategy.
"The acquisition of SR Wholesale marks
the latest step in the Company's growth and expansion strategy, as we continue
to move forward with a positive business outlook focused on achieving revenue
growth, profitability and value creation for our shareholders. We expect this
transaction to serve as a launchpad for Red Light Holland to broaden
operations, create new homes for our iMicrodose packs and build brand exposure
into multiple European markets. Others companies in the sector can keep telling
people or assuming how people should consume psilocybin years from now, while
we will continue offering people what they want right now, while concentrating
on immediate revenue, profit and growth" said Todd Shapiro, Chief
Executive Officer and Director of the Company. "We are quite thrilled,
after months of tough negotiations and careful due diligence, to move forward
as the largest legal psychedelic distribution publicly traded company in the
world.[2] As well, we are truly so pleased to work closely with Mr. Shai Ramsahai,
who is one of the brightest, most determined and likeable entrepreneurs I've
ever come across. And he is an absolute legend in the Netherlands!"
Other
companies in the psychedelic mushroom sector include MindMed (OTC: MMEDF), a clinical-stage
psychedelic medicine biotech company that discovers, develops and deploys
psychedelic inspired medicines and therapies to address addiction and mental
illness. The company is assembling a
drug development pipeline of innovative treatments based on psychedelic
substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative,
18-MC. The Company is expanding its reach in psychedelic research and recently announced,” MindMed
Announces the Publication of New Data on Personalized MDMA Dosing.”
According to Fortune
Business Insights,
“The global mushroom market was valued at 12.74
million tons (MT) in 2018 and is projected to reach 20.84 million tons (MT) by
2026, exhibiting a CAGR of 6.41% in the forecast period.”
As new research and developments provide mounting
evidence supporting the use of functional and psychedelic mushrooms as
sustainable, healthy medical and food alternatives, it seems the fantastic
world of fungi will be the topic of much discussion for years to come.
About
Investorideas.com - Investorideas.com is a recognized news
source publishing third party news, research and original financial content.
Learn about investing in stocks and sector trends with our news alerts,
articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI Eye
Disclaimer/Disclosure
:Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
management and IR of each company directly regarding specific questions.
Disclosure: this news article featuring LRSV is a paid for news release on
Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800-665-0411
Health, Wellness and Sustainability Stocks Research and News at
Investorideas.com - investing ideas for a better world
Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and
stock directories
No comments:
Post a Comment